• Something wrong with this record ?

DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes

SA. Farkas, V. Vymetalkova, L. Vodickova, P. Vodicka, TK. Nilsson,

. 2014 ; 6 (2) : 179-191.

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19025220

Grant support
NT14329 MZ0 CEP Register

Digital library NLK
Full text - Article
Source

E-resources Online Full text

NLK ProQuest Central from 2009-10-01 to 2020-03-31
Health & Medicine (ProQuest) from 2009-10-01 to 2020-03-31

Links

PubMed 24811787
DOI 10.2217/epi.14.7
Knihovny.cz E-resources

AIM: The onset and progression of colorectal cancer (CRC) involves a cascade of genetic and/or epigenetic events. The aim of the present study was to address the DNA methylation status of genes relevant in colorectal carcinogenesis and its progression, such as genes frequently mutated in CRC, genes involved in the DNA repair and Wnt signaling pathway. MATERIAL & METHODS: We analyzed methylation status in totally 160 genes in 12 paired colorectal tumors and adjacent healthy mucosal tissues using the Illumina Infinium Human Methylation 450 BeadChip. RESULTS: We found significantly aberrant methylation in 23 genes (NEIL1, NEIL3, DCLRE1C, NHEJ1, GTF2H5, CCNH, CTNNB1, DKK2, DKK3, FZD5 LRP5, TLE3, WNT2, WNT3A, WNT6, TCF7L1, CASP8, EDNRB1, GPC6, KIAA1804, MYO1B, SMAD2 and TTN). External validation by mRNA expression showed a good agreement between hypermethylation in cancer and down-regulated mRNA expression of the genes EDNRB1, GPC6 and SMAD2, and between hypomethylation and up-regulated mRNA expression of the CASP8 and DCLRE1C genes. CONCLUSION: Aberrant methylation of the DCLRE1C and GPC6 genes are presented here for the first time and are therefore of special interest for further validation as novel candidate biomarker genes in CRC, and merit further validation with specific assays.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19025220
003      
CZ-PrNML
005      
20200605141741.0
007      
ta
008      
190710s2014 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.2217/epi.14.7 $2 doi
035    __
$a (PubMed)24811787
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Farkas, Sanja A $u Department of Laboratory Medicine, Örebro University Hospital; Örebro, Sweden.
245    10
$a DNA methylation changes in genes frequently mutated in sporadic colorectal cancer and in the DNA repair and Wnt/β-catenin signaling pathway genes / $c SA. Farkas, V. Vymetalkova, L. Vodickova, P. Vodicka, TK. Nilsson,
520    9_
$a AIM: The onset and progression of colorectal cancer (CRC) involves a cascade of genetic and/or epigenetic events. The aim of the present study was to address the DNA methylation status of genes relevant in colorectal carcinogenesis and its progression, such as genes frequently mutated in CRC, genes involved in the DNA repair and Wnt signaling pathway. MATERIAL & METHODS: We analyzed methylation status in totally 160 genes in 12 paired colorectal tumors and adjacent healthy mucosal tissues using the Illumina Infinium Human Methylation 450 BeadChip. RESULTS: We found significantly aberrant methylation in 23 genes (NEIL1, NEIL3, DCLRE1C, NHEJ1, GTF2H5, CCNH, CTNNB1, DKK2, DKK3, FZD5 LRP5, TLE3, WNT2, WNT3A, WNT6, TCF7L1, CASP8, EDNRB1, GPC6, KIAA1804, MYO1B, SMAD2 and TTN). External validation by mRNA expression showed a good agreement between hypermethylation in cancer and down-regulated mRNA expression of the genes EDNRB1, GPC6 and SMAD2, and between hypomethylation and up-regulated mRNA expression of the CASP8 and DCLRE1C genes. CONCLUSION: Aberrant methylation of the DCLRE1C and GPC6 genes are presented here for the first time and are therefore of special interest for further validation as novel candidate biomarker genes in CRC, and merit further validation with specific assays.
650    _2
$a senioři $7 D000368
650    _2
$a kolorektální nádory $x genetika $7 D015179
650    _2
$a CpG ostrůvky $x genetika $7 D018899
650    _2
$a metylace DNA $x genetika $7 D019175
650    _2
$a oprava DNA $x genetika $7 D004260
650    _2
$a endonukleasy $7 D004720
650    _2
$a epigeneze genetická $7 D044127
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a glypikany $x genetika $7 D053673
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a jaderné proteiny $x genetika $7 D009687
650    _2
$a promotorové oblasti (genetika) $7 D011401
650    _2
$a messenger RNA $x biosyntéza $7 D012333
650    _2
$a proteiny Wnt $x genetika $7 D051153
650    _2
$a signální dráha Wnt $x genetika $7 D060449
650    _2
$a beta-katenin $x genetika $7 D051176
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vymetálková, Veronika $7 xx0102721
700    1_
$a Vodičková, Ludmila $7 xx0128157
700    1_
$a Vodička, Pavel $7 xx0060269
700    1_
$a Nilsson, Torbjörn K
773    0_
$w MED00174308 $t Epigenomics $x 1750-1911 $g Roč. 6, č. 2 (2014), s. 179-191
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24811787 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y 4 $z 0
990    __
$a 20190710 $b ABA008
991    __
$a 20200605141739 $b ABA008
999    __
$a ok $b bmc $g 1422760 $s 1063645
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 6 $c 2 $d 179-191 $i 1750-1911 $m Epigenomics $n Epigenomics $x MED00174308
GRA    __
$a NT14329 $p MZ0
LZP    __
$a Pubmed-20190710

Find record

Citation metrics

    Archiving options